TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage-Reference-Cited by-全球学者库

TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage

Published:2020-06-30 Issue:3 Volume:72 Page:923-939
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Dong Zhao‐Ru¹,Sun Dong¹²,Yang Ya‐Fei¹,Zhou Wei¹,Wu Rui¹,Wang Xiao‐Wei³,Shi Kai¹,Yan Yu‐Chuan¹,Yan Lun‐Jie¹,Yao Cheng‐Yu¹,Chen Zhi‐Qiang¹,Zhi Xu‐Ting¹,Li Tao¹

Affiliation:

1. Department of General Surgery Qilu Hospital Shandong University Jinan China

2. The First Central Clinical College Tianjin Medical University Tianjin China

3. The Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education and Chinese Ministry of Health Qilu Hospital Shandong University Jinan China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31076

Reference36 articles.

1. Hepatocellular carcinoma

2. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

3. Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

4. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

5. Might Sorafenib combined with radiotherapy be better option for treating hepatocellular carcinoma with portal vein tumour thrombosis?

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the power of microenvironment in liver regeneration: an in-depth overview;Frontiers in Genetics;2023-12-13

2. Predictive Roles of ADAM17 in Patient Survival and Immune Cell Infiltration in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-12-02

3. Design of a novel multi-epitope vaccine candidate against endometrial cancer using immunoinformatics and bioinformatics approaches;Journal of Biomolecular Structure and Dynamics;2023-09-28

4. MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway;Cancer Cell International;2023-08-31

5. Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity;Cell Death & Disease;2023-07-06